Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
22.73
-3.91 (-14.66%)
Mar 31, 2025, 1:21 PM EDT - Market open

Vera Therapeutics Stock Forecast

Stock Price Forecast

The 8 analysts with 12-month price forecasts for Vera Therapeutics stock have an average target of 65.5, with a low estimate of 38 and a high estimate of 107. The average target predicts an increase of 188.23% from the current stock price of 22.73.

Analyst Consensus: Buy
Target Low Average Median High
Price $38 $65.5 $68 $107
Change +67.22% +188.23% +199.23% +370.85%

Analyst Ratings

The average analyst rating for Vera Therapeutics stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 433322
Buy 455555
Hold 111111
Sell 000000
Strong Sell 000000
Total 999988

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
JP Morgan
JP Morgan
Buy
Maintains
$77$71
Buy Maintains $77$71 +212.43% Mar 4, 2025
Guggenheim
Guggenheim
Strong Buy
Maintains
$59$61
Strong Buy Maintains $59$61 +168.43% Feb 27, 2025
Wolfe Research
Wolfe Research
Buy
Initiates
$49
Buy Initiates $49 +115.62% Feb 4, 2025
Wells Fargo
Wells Fargo
Buy
Initiates
$70
Buy Initiates $70 +208.03% Nov 21, 2024
Wedbush
Wedbush
Hold
Maintains
$30$38
Hold Maintains $30$38 +67.22% Nov 8, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 942.65M
Revenue Next Year
n/a
EPS This Year
-3.23
from -2.75
EPS Next Year
-3.06
from -3.23
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028 FY 2029
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028 Dec 31, 2029
Revenue
-46.11M195.38M551.29M942.65M
Revenue Growth
--323.77%182.16%70.99%---
EPS
-166.93-2.43-3.35-2.25-2.75-3.23-3.06-0.10
EPS Growth
--------
Forward PE
--------
No. Analysts -----13103
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High n/a 85.8M 323.0M
Avg n/a 46.1M 195.4M
Low n/a 7.7M 79.7M

Revenue Growth

Revenue Growth 20252026202720282029
High - -
600.5%
Avg - -
323.8%
Low - -
72.8%

EPS Forecast

EPS 202520262027
High -2.33 -2.38 -0.11
Avg -3.23 -3.06 -0.10
Low -4.62 -3.95 -0.10

EPS Growth

EPS Growth 202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.